-
Sea waste recycling project reaches semi-finals of national entrepreneurship programme
A project that aims to collect waste discarded in seas and rivers and turn it into useful materials has made it to the semi-finals of a national entrepreneurial development programme.
-
University paper among the 'most mentioned' in 2019
An academic paper by a University of Aberdeen researcher has made it on to the annual list of the top 100 most-mentioned scholarly articles published in 2019.
-
Award for outstanding geneticist
Dr Jonathan Pettitt from the School of Medicine, Medical Sciences and Nutrition has been recognised by the UK's Genetics Society for their outstanding contribution to public engagement with science, by being asked to deliver the 2020 JBS Haldane Lecture.
-
UK universities will work together to improve research quality and reproducibility
The University of Aberdeen is one of 10 UK universities which will collaborate to improve the quality of UK academic research output, it was announced today.
-
New cannabinoid research shows potential for targeted drug therapy
Gene region could identify people who may benefit most from medical cannabis.
-
University governors back transformational plans to revitalise historic campus
The University of Aberdeen has taken the next steps towards multi-million pound ambitions to revitalise the heart of its historic King's College campus to continue to provide a 'world class' learning experience for its growing student population.
-
Prestigious honour for Aberdeen academic
A University of Aberdeen academic has received the highest honour that can be bestowed upon a scientist by China.
-
Researchers find new evidence that a 'smart, fungi' can be hard to find
A team of experts have discovered that a common fungus that infects humans can not only predict an imminent attack from the immune system, it will even change its appearance to hide from it.
-
Researchers test drugs with potential to restore sight loss from aniridia
Researchers at the University of Aberdeen will test two repurposed drugs for the treatment of the rare eye condition aniridia, which causes blindness thanks to funding from Fight for Sight.